Subsidy Information and Financing Scheme MSHLLurbinectedin Powder For Solution For Infusion 4 mg Treatment of patients with metastatic small cell lung cancer (SCLC) who have progressed after prior... See all × MSHLLurbinectedin Powder For Solution For Infusion 4 mg Treatment of patients with metastatic small cell lung cancer (SCLC) who have progressed after prior platinum-containing therapy.
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Powder For Solution For Infusion 4 mg National Cancer Centre
INTRAVENOUS Select a brand starting with the letter: Z ZEPZELCA POWDER FOR SOLUTION FOR INFUSION 4MG/VIAL [SIN16327P]